Focused Alpha LLC Makes New Investment in UnitedHealth Group Incorporated $UNH

Focused Alpha LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,555 shares of the healthcare conglomerate’s stock, valued at approximately $571,000.

Several other institutional investors have also made changes to their positions in UNH. Corient Private Wealth LP acquired a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $245,516,000. Legal & General Group Plc purchased a new stake in shares of UnitedHealth Group during the second quarter worth $2,444,928,000. Jupiter Topco LLC acquired a new stake in UnitedHealth Group during the second quarter valued at $2,019,844,000. BlackRock Inc. grew its stake in UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after purchasing an additional 3,395,530 shares in the last quarter. Finally, Canada Pension Plan Investment Board purchased a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $971,757,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently commented on UNH shares. Raymond James Financial reissued an “outperform” rating and issued a $450.00 price target on shares of UnitedHealth Group in a research note on Thursday. BMO Capital Markets set a $512.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $370.00 to $467.00 and gave the stock a “hold” rating in a research report on Friday, July 17th. Morgan Stanley raised their price target on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a report on Friday, July 17th. Finally, Bank of America reiterated a “buy” rating and issued a $450.00 price objective on shares of UnitedHealth Group in a report on Monday, July 20th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $463.57.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 earnings beat and higher guidance support the stock. UnitedHealth reported adjusted earnings of $4.69 per share, above the $4.14 consensus estimate, while revenue of $112.7 billion also exceeded expectations. Management raised its 2026 adjusted earnings guidance to at least $20.50 per share, reinforcing confidence in operating performance and medical-cost management. UnitedHealth Group Has The Market Asking A Bigger Question
• Positive Sentiment: Analyst and investor interest has strengthened. Recent momentum following the earnings report has renewed attention on UnitedHealth’s medical-cost trends and execution. A JPMorgan analyst also expects the stock to rise, while healthcare ETF commentary highlights UNH as an attractive holding for diversified sector exposure. UnitedHealth Group Stock Price Expected to Rise
• Neutral Sentiment: AI remains a broader healthcare investment theme. Articles identify artificial intelligence, data-driven testing and biointelligence as growth drivers across healthcare, but the highlighted beneficiaries are primarily Guardant Health, Illumina, Eli Lilly and Moderna rather than UnitedHealth directly. The AI Trade Just Moved Into Your Bloodstream
• Negative Sentiment: Enrollment losses could pressure parts of the insurance business. KFF research shows individual-market enrollment fell 18% to 20.5 million in 2026, with remaining customers facing substantially higher premiums. The impact on UNH may be limited by its broader business mix, but shrinking enrollment is an industry risk. Americans Leave Health Insurance Market
• Negative Sentiment: Medicare Advantage disruption and valuation temper enthusiasm. About 3.2 million seniors may lose their Medicare Advantage plans in 2027, potentially increasing member-retention and regulatory challenges. Separately, one analyst downgraded UNH from “strong buy” to “buy,” arguing that a valuation near 20 times forward earnings already reflects much of the recovery. UnitedHealth Rating Downgrade

UnitedHealth Group Stock Up 1.4%

Shares of UnitedHealth Group stock opened at $406.99 on Tuesday. UnitedHealth Group Incorporated has a 12-month low of $255.96 and a 12-month high of $461.62. The stock has a market capitalization of $365.31 billion, a P/E ratio of 23.24, a PEG ratio of 1.45 and a beta of 0.60. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The stock has a 50 day moving average price of $387.04 and a two-hundred day moving average price of $386.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.70 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same period in the previous year, the company earned $2.59 earnings per share. UnitedHealth Group’s revenue for the quarter was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 20.64 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were issued a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s dividend payout ratio is 53.00%.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.19% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.